DPP4 and diabetes mellitus: While there is a lack of studies exploring the association between diabetes mellitus and IBD, it has been reported that the use of metformin and dipeptidyl peptidase-4 inhibitors, which are the most frequently prescribed drugs for the management of diabetes mellitus in South Korea (44), could mitigate the risk of IBD in patients with diabetes mellitus (45, 46).